Evidence map›Paper›PMID 34744175›Full record

ArticleGenus2021

Investigating regional excess mortality during 2020 COVID-19 pandemic in selected Latin American countries.

Everton E C Lima, Estevão A Vilela, Andrés Peralta, Marília Rocha, Bernardo L Queiroz, Marcos R Gonzaga, Mario Piscoya-Díaz, Kevin Martinez-Folgar, Víctor M García-Guerrero, Flávio H M A Freire

Abstract read
In one paragraph

Article in Genus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Mortality burden of malignant neoplasms of the corpus uteri in Mexico: an analysis of trends from 2000 to 2022.Revista brasileira de epidemiologia = Brazilian journal of epidemiology · 2026
    Article
  4. COVID-19 on Elective Surgery Outcomes in a Brazilian Tertiary Hospital: A Retrospective Cohort Study.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Article
  5. Article
  6. Article
  7. Serologic Evidence for Early SARS-CoV-2 Circulation in Lima, Peru, 2020.The American journal of tropical medicine and hygiene · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Immediate and contributory causes of death in patients hospitalized with COVID-19.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Pandemic justice for and from Latin America.Ethic@ : an international journal for moral philosophy = Revista internacional de filosofia da moral · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Everton E C LimaUniversidade Estadual de Campinas, Campinas, Brazil.ORCID 0000-0001-6275-9854
Estevão A VilelaUniversidade Federal de Minas Gerais, Belo Horizonte, Brazil.ORCID 0000-0003-0790-0194
Andrés PeraltaPublic Health Institute, Pontifical Catholic University of Ecuador (PUCE) - Ecuador, Quito, Ecuador.
Marília RochaUniversidade Estadual de Campinas, Campinas, Brazil.ORCID 0000-0002-4394-2423
Bernardo L QueirozUniversidade Federal de Minas Gerais, Belo Horizonte, Brazil.ORCID 0000-0002-2890-1025
Marcos R GonzagaDepartamento de Demografia e Ciências Atuariais, Universidade Federal do Rio Grande do Norte, Natal, Brazil.ORCID 0000-0002-6088-3453
Mario Piscoya-DíazUniversidade Federal de Goias, Goiânia, Brazil.
Kevin Martinez-FolgarUrban Health Collaborative & Department of Epidemiology and Biostatistics, Dornsife School of Public Health, Drexel University, Philadelphia, PA USA.ORCID 0000-0001-9262-298X
Víctor M García-GuerreroEl Colegio de México, Mexico City, Mexico.ORCID 0000-0003-1367-9262
Flávio H M A FreireDepartamento de Demografia e Ciências Atuariais, Universidade Federal do Rio Grande do Norte, Natal, Brazil.ORCID 0000-0002-7416-9947

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this paper, we measure the effect of the 2020 COVID-19 pandemic wave at the national and subnational levels in selected Latin American countries that were most affected: Brazil, Chile, Ecuador, Guatemala, Mexico, and Peru. We used publicly available monthly mortality data to measure the impacts of the pandemic using excess mortality for each country and its regions. We compare the mortality, at national and regional levels, in 2020 to the mortality levels of recent trends and provide estimates of the impact of mortality on life expectancy at birth. Our findings indicate that from April 2020 on, mortality exceeded its usual monthly levels in multiple areas of each country. In Mexico and Peru, excess mortality was spreading through many areas by the end of the second half of 2020. To a lesser extent, we observed a similar pattern in Brazil, Chile, and Ecuador. We also found that as the pandemic progressed, excess mortality became more visible in areas with poorer socioeconomic and sanitary conditions. This excess mortality has reduced life expectancy across these countries by 2-10 years. Despite the lack of reliable information on COVID-19 mortality, excess mortality is a useful indicator for measuring the effects of the coronavirus pandemic, especially in the context of Latin American countries, where there is still a lack of good information on causes of death in their vital registration systems. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41118-021-00139-1.

Indexed as

COVID-19Excess mortalityLatin AmericaPandemicSubnational areas

Identifiers

PMID34744175
PMCPMC8564791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.